AbCellera Biologics Inc. — Investor Relations & Filings
Filings indexed
293
across all filing types
Latest filing
2026-06-05
Board/Management Inform…
Country
CA
Canada
Listing
US
ABCL
AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, full-stack technology platform that integrates biology, computation, and engineering to search and analyze natural immune systems for therapeutic antibodies. This engine is designed to accelerate the development of first-in-class and best-in-class medicines. AbCellera advances its own internal pipeline and also partners with other pharmaceutical and biotech companies to address challenging drug discovery problems. Its capabilities support programs involving complex targets such as transmembrane proteins, bispecifics, and antibody drug conjugates for conditions with high unmet medical need.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-06-05 | English | |
| 10-Q - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-05-11 | English | |
| ARS - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | |
| DEF 14A - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | |
| 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-03-02 | English | |
| 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-27 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 47982032 | 8-K | 2026-06-05 | English | ||
| 45000144 | 10-Q - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-05-11 | English | ||
| 38777908 | ARS - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | ||
| 38740788 | DEF 14A - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | ||
| 32896970 | 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-03-02 | English | ||
| 32896971 | 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-27 | English | ||
| 32896972 | 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-27 | English | ||
| 32896981 | 10-K - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-24 | English | ||
| 32896975 | 8-K - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-24 | English | ||
| 13026668 | 8-K | 2026-01-14 | English | ||
| 13026671 | FORM 4 | 2026-01-05 | English | ||
| 13026672 | FORM 4 | 2026-01-05 | English | ||
| 13026679 | FORM 4 | 2026-01-05 | English | ||
| 13026674 | FORM 4 | 2026-01-05 | English | ||
|
2025
1 filing
| |||||
| 13026673 | FORM 4 | 2025-12-19 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
AbCellera Biologics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31942/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31942 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31942 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31942 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31942}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AbCellera Biologics Inc. (id: 31942)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.